Baird Financial Group
BMY.RT

Baird Financial Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Baird Financial Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-62,008
Closed -$43K – 1751
2020
Q4 		$43K Sell
62,008
-24,622
-28% -$52.4K ﹤0.01% 1558
2020
Q3 		$195K Sell
86,630
-2,561
-3% -$7.31K ﹤0.01% 1410
2020
Q2 		$319K Sell
89,191
-6,889
-7% -$24.9K ﹤0.01% 1282
2020
Q1 		$364K Sell
96,080
-17,518
-15% -$57.7K ﹤0.01% 1151
2019
Q4 		$342K Buy
+113,598
New +$295K ﹤0.01% 1282

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Baird Financial Group's BMY.RT Position: Q1 2021 in Review

Baird Financial Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 62,008 shares — an estimated $43K sold.

Baird Financial Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $364K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Baird Financial Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Baird Financial Group sold 62,008 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $43K.
  • Baird Financial Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Baird Financial Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $364K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Baird Financial Group's 13F filing for Q1 2021, filed 13 May 2021.